Waters highlights continued progress towards sustainability commitments to reduce environmental impact: Our Bureau, Bengaluru Thursday, December 12, 2024, 15:40 Hrs [IST] Waters h ...
In a groundbreaking initiative aimed at accelerating the fight against tuberculosis (TB), healthcare leaders from corporate and private hospitals across Uttar Pradesh came together in Ghaziabad. The ...
NIH study finds tecovirimat was safe but did not improve mpox resolution or pain: Bethesda, Maryland Thursday, December 12, 2024, 15:00 Hrs [IST] The antiviral drug tecovirimat di ...
UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema: United Kingdom Thursday, December 12, 20 ...
Orbis India sees bright future begins with clear vision calls for early eye care in children: Our Bureau, Bengaluru Thursday, December 12, 2024, 13:50 Hrs [IST] Orbis India, a non ...
Cellectar Biosciences updates on clinical development on its proprietary phospholipid ether drug conjugate platform targeting cancers: Florham Park, New Jersey Thursday, December ...
Inventurus Knowledge Solutions raises Rs. 1,120.18 crore from 61 anchor investors: Our Bureau, Mumbai Thursday, December 12, 2024, 13:30 Hrs [IST] Inventurus Knowledge Solutions L ...
Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released. At least 1 person each ...
Daiichi Sankyo begins patient dosing in QuANTUM-Wild phase 3 trial of Vanflyta in newly diagnosed FLT3-ITD negative AML: Tokyo Thursday, December 12, 2024, 12:00 Hrs [IST] The fir ...
New advances in carbon ion therapy for challenging large tumours: Study: Krems, Austria Thursday, December 12, 2024, 11:00 Hrs [IST] A pioneering study has introduced a novel appr ...
NABL announces major overhaul with accreditation validity extended to 4 years for testing labs: Shardul Nautiyal, Mumbai ...
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections: Paris Thursday, December 12, 2024, 10:00 Hrs [IST ...